Cerca
Cerca
+

ESMO Annual Meeting 2019: Menarini Ricerche Presents the Preclinical Characterization of MEN1611, a Novel PI3K Inhibitor in Development for the Treatment of Breast Cancer

default_image

AdnKronos
  • a
  • a
  • a

Dai blog